In vivo reflectance confocal microscopy can detect the invasive component of lentigo maligna melanoma: Prospective analysis and case-control study.
Journal
Journal of the European Academy of Dermatology and Venereology : JEADV
ISSN: 1468-3083
Titre abrégé: J Eur Acad Dermatol Venereol
Pays: England
ID NLM: 9216037
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
24
09
2022
accepted:
08
02
2023
medline:
14
6
2023
pubmed:
2
3
2023
entrez:
1
3
2023
Statut:
ppublish
Résumé
Lentigo maligna (LM), a form of melanoma in situ, has no risk of causing metastasis unless dermal invasive melanoma (LMM) supervenes. Furthermore, the detection of invasion impacts prognosis and management. To assess the accuracy of RCM for the detection of invasion component on LM/LMM lesions. In the initial case-control study, the performance of one expert in detecting LMM at the time of initial RCM assessment of LM/LMM lesions was recorded prospectively (n = 229). The cases were assessed on RCM-histopathology correlation sessions and a panel with nine RCM features was proposed to identify LMM, which was subsequently tested in a subset of initial cohort (n = 93) in the matched case-control study by two blinded observers. Univariable and multivariable logistic regression models were performed to evaluate RCM features predictive of LMM. Reproducibility of assessment of the nine RCM features was also evaluated. A total of 229 LM/LMM cases evaluated by histopathology were assessed blindly and prospectively by an expert confocalist. On histopathology, 210 were LM and 19 were LMM cases. Correct identification of an invasive component was achieved for 17 of 19 LMM cases (89%) and the absence of a dermal component was correctly diagnosed in 190 of 210 LM cases (90%). In the matched case-control (LMM n = 35, LM n = 58), epidermal and junctional disarray, large size of melanocytes and nests of melanocytes were independent predictors of LMM on multivariate analysis. The interobserver analysis demonstrated that these three features had a fair reproducibility between the two investigators (K = 0.4). The multivariable model including those three features showed a high predictive performance AUC = 74% (CI 95% 64-85%), with sensitivity of 63% (95% CI 52-78%) and specificity of 79% (CI 95% 74-88%), and likelihood ratio of 18 (p-value 0.0026). Three RCM features were predictive for identifying invasive melanoma in the background of LM.
Sections du résumé
BACKGROUND
BACKGROUND
Lentigo maligna (LM), a form of melanoma in situ, has no risk of causing metastasis unless dermal invasive melanoma (LMM) supervenes. Furthermore, the detection of invasion impacts prognosis and management.
OBJECTIVE
OBJECTIVE
To assess the accuracy of RCM for the detection of invasion component on LM/LMM lesions.
METHODS
METHODS
In the initial case-control study, the performance of one expert in detecting LMM at the time of initial RCM assessment of LM/LMM lesions was recorded prospectively (n = 229). The cases were assessed on RCM-histopathology correlation sessions and a panel with nine RCM features was proposed to identify LMM, which was subsequently tested in a subset of initial cohort (n = 93) in the matched case-control study by two blinded observers. Univariable and multivariable logistic regression models were performed to evaluate RCM features predictive of LMM. Reproducibility of assessment of the nine RCM features was also evaluated.
RESULTS
RESULTS
A total of 229 LM/LMM cases evaluated by histopathology were assessed blindly and prospectively by an expert confocalist. On histopathology, 210 were LM and 19 were LMM cases. Correct identification of an invasive component was achieved for 17 of 19 LMM cases (89%) and the absence of a dermal component was correctly diagnosed in 190 of 210 LM cases (90%). In the matched case-control (LMM n = 35, LM n = 58), epidermal and junctional disarray, large size of melanocytes and nests of melanocytes were independent predictors of LMM on multivariate analysis. The interobserver analysis demonstrated that these three features had a fair reproducibility between the two investigators (K = 0.4). The multivariable model including those three features showed a high predictive performance AUC = 74% (CI 95% 64-85%), with sensitivity of 63% (95% CI 52-78%) and specificity of 79% (CI 95% 74-88%), and likelihood ratio of 18 (p-value 0.0026).
CONCLUSION
CONCLUSIONS
Three RCM features were predictive for identifying invasive melanoma in the background of LM.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1293-1301Subventions
Organisme : Melanoma Institute Australia
Organisme : MetaOptima Technology Incl., Hoffmann-La Roche Ltd, Evaxion, Provectus Biopharmaceuticals Australia, Qbiotics, Novartis, Merck Sharp & Dohme, NeraCare, AMGEN Inc., Bristol-Myers Squibb, Myriad Genetics, GlaxoSmithKline.
ID : N/A
Organisme : NHMRC Practitioner Fellowship
ID : APP1141295
Informations de copyright
© 2023 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology.
Références
Dermatol Surg. 2021 Apr 1;47(4):473-479
pubmed: 33625139
J Am Acad Dermatol. 2013 Mar;68(3):e73-82
pubmed: 22000768
Australas J Dermatol. 2019 May;60(2):118-125
pubmed: 30302753
J Invest Dermatol. 2010 Aug;130(8):2080-91
pubmed: 20393481
Int J Dermatol. 2022 Feb;61(2):167-174
pubmed: 34351639
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):74-81
pubmed: 31325402
Melanoma Res. 2020 Apr;30(2):193-197
pubmed: 31095041
Dermatol Pract Concept. 2021 May 20;11(3):e2021068
pubmed: 34123564
Dermatol Clin. 2016 Oct;34(4):421-429
pubmed: 27692448
J Eur Acad Dermatol Venereol. 2023 Jul;37(7):1293-1301
pubmed: 36855833
J Clin Oncol. 2009 Dec 20;27(36):6199-206
pubmed: 19917835
Br J Dermatol. 2009 Dec;161(6):1307-16
pubmed: 19566662
J Am Acad Dermatol. 2023 Sep;89(3):e125-e126
pubmed: 35085680
Arch Dermatol Res. 2021 Sep;313(7):517-529
pubmed: 32844312
Dermatol Surg. 2018 Feb;44(2):159-174
pubmed: 29059147
J Eur Acad Dermatol Venereol. 2014 Aug;28(8):1069-78
pubmed: 24147614
Hum Pathol. 2000 Jun;31(6):705-8
pubmed: 10872664